A monoclonal antibody, anti-M7, specifically blocks the interaction of Mac-1 with CD40L resulting in reduced leukocyte recruitment and cytokine secretion, improving sepsis outcomes by preventing excessive inflammation and enhancing bacterial clearance (64). This evidence concerns the gene ITGB2 and Sepsis.